NASDAQ:RWLK ReWalk Robotics (RWLK) Stock Price, News & Analysis → The CHIPS Act Motherlode (From True Market Insiders) (Ad) Free RWLK Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.64▼$1.2552-Week Range N/AVolume303,600 shsAverage Volume541,468 shsMarket Capitalization$63.04 millionP/E RatioN/ADividend YieldN/APrice Target$3.00 Stock AnalysisStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Get ReWalk Robotics alerts: Email Address ReWalk Robotics MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside∞ Upside$3.00 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.38) to ($0.37) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.80 out of 5 starsMedical Sector836th out of 920 stocksMedical Devices Industry2nd out of 2 stocks 3.5 Analyst's Opinion Consensus RatingReWalk Robotics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageReWalk Robotics has received no research coverage in the past 90 days.Read more about ReWalk Robotics' stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for RWLK. Previous Next 0.0 Dividend Strength Dividend YieldReWalk Robotics does not currently pay a dividend.Dividend GrowthReWalk Robotics does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for RWLK. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 2 news articles for ReWalk Robotics this week, compared to 1 article on an average week.Search Interest2 people have searched for RWLK on MarketBeat in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ReWalk Robotics insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.10% of the stock of ReWalk Robotics is held by insiders.Percentage Held by InstitutionsOnly 3.58% of the stock of ReWalk Robotics is held by institutions.Read more about ReWalk Robotics' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for ReWalk Robotics are expected to grow in the coming year, from ($0.38) to ($0.37) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of ReWalk Robotics is -2.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of ReWalk Robotics is -2.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad True Market InsidersThe CHIPS Act MotherlodeIf you haven’t heard yet, the CHIPS Act is the US government pouring $280 BILLION into the manufacturing of US semiconductors. A lot of companies will make a fortune from this.Click here to see my #1 investment for 2024. About ReWalk Robotics Stock (NASDAQ:RWLK)ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.Read More Ad True Market InsidersThe CHIPS Act MotherlodeIf you haven’t heard yet, the CHIPS Act is the US government pouring $280 BILLION into the manufacturing of US semiconductors. A lot of companies will make a fortune from this.Click here to see my #1 investment for 2024. RWLK Stock News HeadlinesMay 16 at 10:32 AM | msn.comReWalk Robotics Ltd. (NASDAQ:LFWD) Q1 2024 Earnings Call TranscriptMay 14, 2024 | markets.businessinsider.comReWalk Robotics earnings: here's what Wall Street expectsMay 10, 2024 | markets.businessinsider.comReWalk Robotics Ltd hosts conference call for investorsApril 18, 2024 | finance.yahoo.comReWalk Robotics Ltd. (LFWD)March 22, 2024 | globenewswire.comVA STAND Act introduced in the United States SenateMarch 13, 2024 | globenewswire.comLifeward Announces Reverse Share SplitMarch 8, 2024 | globenewswire.comReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke TherapyMarch 1, 2024 | globenewswire.comLifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be consideredFebruary 27, 2024 | globenewswire.comLifeward Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 20, 2024 | globenewswire.comLifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024February 15, 2024 | uk.investing.comRewalk Robotics Ltd (LFWD)February 15, 2024 | uk.investing.comRewalk Robotics Ltd (RWLK)February 13, 2024 | cnn.comReWalk Robotics Ltd.February 6, 2024 | finance.yahoo.com7 ‘AgeTech’ Stocks to Profit From the Booming Longevity MarketJanuary 31, 2024 | finanznachrichten.deReWalk Robotics Ltd. (DBA Lifeward): ReWalk Robotics Transforms Company Identity, Rebrands as LifewardJanuary 31, 2024 | msn.comRewalk Robotics Rebrands as Lifeward, Announces New TickerJanuary 15, 2024 | finance.yahoo.comReWalk Robotics (NASDAQ:RWLK investor five-year losses grow to 82% as the stock sheds US$10m this past weekJanuary 12, 2024 | finance.yahoo.comReWalk Robotics Expands Direct Sales Coverage to CanadaJanuary 11, 2024 | finance.yahoo.comReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17January 5, 2024 | finanznachrichten.deReWalk Robotics Ltd.: First ReWalk Personal Exoskeleton Claim Paid by MedicareJanuary 5, 2024 | finance.yahoo.comFirst ReWalk Personal Exoskeleton Claim Paid by MedicareJanuary 4, 2024 | finance.yahoo.comReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational PrioritiesNovember 30, 2023 | finance.yahoo.comReWalk Robotics Presents on Personal Exoskeleton Pricing at Medicare Public MeetingNovember 28, 2023 | finanznachrichten.deReWalk Robotics Ltd.: ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton PrototypeNovember 28, 2023 | finance.yahoo.comReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton PrototypeSee More Headlines Receive RWLK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ReWalk Robotics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/11/2021Today5/19/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolNASDAQ:RWLK CUSIPN/A CIK1607962 Webwww.rewalk.com Phone(724) 959-0123FaxN/AEmployees56Year FoundedN/APrice Target and Rating Average Stock Price Target$3.00 High Stock Price Target$3.00 Low Stock Price Target$3.00 Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.37) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-19,570,000.00 Net Margins-238.35% Pretax Margin-233.51% Return on Equity-29.00% Return on Assets-25.27% Debt Debt-to-Equity RatioN/A Current Ratio3.47 Quick Ratio2.99 Sales & Book Value Annual Sales$5.51 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$1.10 per share Price / BookN/AMiscellaneous Outstanding Shares60,030,000Free Float58,764,000Market Cap$63.04 million OptionableOptionable Beta2.30 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Lawrence J. Jasinski BS (Age 67)MBA, CEO & Director Comp: $654.03kMr. Michael A. Lawless (Age 56)Chief Financial Officer Comp: $110.24kMs. Miri Pariente (Age 47)Vice President of Operations, Regulatory & Quality Comp: $335.1kMs. Jeannine Lynch (Age 59)Vice President of Market Access & Strategy Comp: $425.98kMs. Kathleen O'DonnellVice President of Marketing & New Business DevelopmentMr. Charles RemsbergChief Sales OfficerMs. Judy KulaVice President of Customer Service, Human Resources & Business AffairsMore ExecutivesKey CompetitorsSHL TelemedicineNASDAQ:SHLTHyperfineNASDAQ:HYPRMural OncologyNASDAQ:MURASEP AcquisitionNASDAQ:SEPAIkena OncologyNASDAQ:IKNAView All CompetitorsInsidersGlobal Fund Lp Lind IIBought 5,031,200 shares on 9/26/2023Total: $3.52 M ($0.70/share)Global Fund Lp Lind IIBought 19,779 shares on 9/5/2023Total: $13,845.30 ($0.70/share)Global Fund Lp Lind IIBought 11,597 shares on 9/1/2023Total: $8,233.87 ($0.71/share)Joseph E Turk JrBought 2,661 shares on 9/1/2023Total: $1,809.48 ($0.68/share)Jeannine LynchSold 9,529 sharesTotal: $6,575.01 ($0.69/share)View All Insider Transactions RWLK Stock Analysis - Frequently Asked Questions Should I buy or sell ReWalk Robotics stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ReWalk Robotics in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" RWLK shares. View RWLK analyst ratings or view top-rated stocks. What is ReWalk Robotics' stock price target for 2024? 1 Wall Street research analysts have issued 12 month price targets for ReWalk Robotics' shares. Their RWLK share price targets range from $3.00 to $3.00. On average, they expect the company's stock price to reach $3.00 in the next twelve months. View analysts price targets for RWLK or view top-rated stocks among Wall Street analysts. How were ReWalk Robotics' earnings last quarter? ReWalk Robotics Ltd. (NASDAQ:RWLK) posted its quarterly earnings results on Thursday, November, 11th. The medical device company reported ($0.06) EPS for the quarter, hitting the consensus estimate of ($0.06). The medical device company had revenue of $1.97 million for the quarter, compared to analyst estimates of $1.60 million. ReWalk Robotics had a negative net margin of 238.35% and a negative trailing twelve-month return on equity of 29.00%. During the same period last year, the business posted ($0.18) earnings per share. What other stocks do shareholders of ReWalk Robotics own? Based on aggregate information from My MarketBeat watchlists, some companies that other ReWalk Robotics investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Calumet Specialty Products Partners (CLMT), Two Harbors Investment (TWO), BlackRock Capital Investment (BKCC), NovoCure (NVCR), Viper Energy (VNOM), Summit Midstream Partners (SMLP), Washington Prime Group (WPG) and Roper Technologies (ROP). This page (NASDAQ:RWLK) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReWalk Robotics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
